Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week open-label safety trial of pregabalin in fibromyalgia patients
2006-001840-30Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in fibromyalgia (FM), sponsored by Pfizer. Primary endpoint: Safety outcomes. Started Jun 2006; status: completed.
02
Drugs
pregabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2006-001840-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001840-30.